Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
E5RG02
UPID:
PRS46_HUMAN
Alternative names:
Serine protease 46 pseudogene
Alternative UPACC:
E5RG02
Background:
Putative serine protease 46, also known as Serine protease 46 pseudogene, represents a unique class of proteolytic enzymes. These enzymes play a pivotal role in various biological processes, including digestion, immune response, and blood coagulation. The specific functions of Putative serine protease 46, however, remain to be fully elucidated.
Therapeutic significance:
Understanding the role of Putative serine protease 46 could open doors to potential therapeutic strategies. Its involvement in critical biological pathways suggests that it could be a target for drug discovery, aiming to modulate its activity in disease conditions.